EGFR and colorectal cancer: These negative results may be due to a lack of efficacy of small molecules inhibitors of EGFR in combination with chemotherapy as in colorectal cancer or to the lack of patient selection (Giaccone et al, 2004; Herbst et al, 2004; Messersmith et al, 2004).